Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

• Main Authors: Adrianna Murphy, PhD (Author), Benjamin Palafox, MSc (Author), Owen O'Donnell, ProfPhD (Author), David Stuckler, ProfPhD (Author), Pablo Perel, PhD (Author), Khalid F AlHabib, ProfMBBS (Author), Alvaro Avezum, ProfPhD (Author), Xiulin Bai, BSc (Author), Jephat Chifamba, ProfDPhil (Author), Clara K Chow, ProfPhD (Author), Daniel J Corsi, PhD (Author), Gilles R Dagenais, MD (Author), Antonio L Dans, MD (Author), Rafael Diaz, MD (Author), Ayse N Erbakan, MD (Author), Noorhassim Ismail, MD (Author), Romaina Iqbal, PhD (Author), Roya Kelishadi, MD (Author), Rasha Khatib, PhD (Author), Fernando Lanas, PhD (Author), Scott A Lear, ProfPhD (Author), Wei Li, ProfPhD (Author), Jia Liu, MSc (Author), Patricio Lopez-Jaramillo, ProfPhD (Author), Viswanathan Mohan, ProfMD (Author), Nahed Monsef, PhD (Author), Prem K Mony, MD (Author), Thandi Puoane, ProfDrPH (Author), Sumathy Rangarajan, MSc (Author), Annika Rosengren, ProfMD (Author), Aletta E Schutte, ProfPhD (Author), Mariz Sintaha, MSc (Author), Koon K Teo, ProfPhD (Author), Andreas Wielgosz, ProfMD (Author), Karen Yeates, MD (Author), Lu Yin, PhD (Author), Khalid Yusoff, ProfMBBS (Author), Katarzyna Zatońska, PhD (Author), Salim Yusuf, ProfPhD (Author), Martin McKee, ProfPhD (Author)
• Format: Book
• Published: Elsevier, 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: There is little evidence on the use of secondary prevention medicines for cardiovascular disease by socioeconomic groups in countries at different levels of economic development. Methods: We assessed use of antiplatelet, cholesterol, and blood-pressure-lowering drugs in 8492 ind...